Product image of Olanzapin Heumann (Olanzapine) supplied by GNH India

Olanzapin Heumann

Active Ingredient:
Olanzapine
Origin:
EU

Olanzapin Heumann (Olanzapine)

Olanzapine, the active ingredient in Olanzapin Heumann, is an atypical antipsychotic presented as an oral tablet for oral administration. It is used to manage symptoms of schizophrenia and bipolar disorder in adult patients, helping to reduce psychotic episodes and stabilize mood.

GNH India supplies Olanzapin Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across global markets. The company adheres to stringent regulatory standards to ensure product integrity throughout the supply chain.

Manufacturer / TM Owner

Heumann Pharma Gmbh & Co. Generica Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Olanzapin Heumann (olanzapine) acts on dopamine and serotonin pathways to treat major psychiatric conditions.
  • Schizophrenia: reduces positive and negative psychotic symptoms, improving overall functioning.
  • Bipolar disorder (manic episodes): stabilizes mood and decreases severity of mania.
  • Maintenance therapy for schizophrenia: helps prevent relapse and sustain symptom control.

How It Works

  • Olanzapine exerts its antipsychotic effect primarily by antagonizing dopamine D2 receptors and serotonin 5‑HT2A receptors in the central nervous system. This combined blockade modulates neurotransmission, diminishing dopaminergic hyperactivity and serotonergic over‑stimulation, which contributes to the reduction of psychotic symptoms and mood stabilization. Additional affinity for histamine H1, muscarinic and α1‑adrenergic receptors may influence its side‑effect profile.

Side Effects

Olanzapin Heumann may be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects

  • Weight gain: increased appetite leading to gradual weight increase.
  • Sedation: drowsiness or feeling unusually sleepy.
  • Dry mouth: reduced salivation causing discomfort.
  • Constipation: slowed gastrointestinal motility.
  • Dizziness: light‑headedness, especially when standing quickly.
  • Increased appetite: may contribute to metabolic changes.

Serious or Rare Side Effects

  • Neuroleptic malignant syndrome: rare but life‑threatening reaction with fever and muscle rigidity.
  • Agranulocytosis: severe drop in white blood cells, increasing infection risk.
  • Seizures: heightened risk in susceptible individuals.
  • Severe hyperglycemia: marked elevation of blood glucose levels.
  • Tardive dyskinesia: involuntary movements after long‑term use.
  • Myocarditis: inflammation of heart muscle, though uncommon.

Precautions & Warnings

  • When prescribing Olanzapin Heumann, clinicians should consider several precautionary measures to ensure patient safety.
  • Metabolic monitoring: regularly assess weight, fasting glucose and lipid profiles.
  • Cardiovascular assessment: evaluate for orthostatic hypotension and ECG changes.
  • Seizure risk: use caution in patients with a history of seizures.
  • Elderly patients: avoid use in dementia‑related psychosis due to increased mortality risk.
  • Discontinuation: taper gradually to reduce risk of withdrawal or relapse.
  • Store at room temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Olanzapin Heumann can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • CYP1A2 inhibitors (e.g., fluvoxamine): may raise olanzapine plasma levels, increasing toxicity risk.
  • CNS depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression.
  • Anticholinergic agents: may exacerbate cognitive impairment.

Moderate Interactions (Monitor Closely)

  • CYP1A2 inducers (e.g., smoking, carbamazepine): may reduce olanzapine exposure, lowering effectiveness.
  • Antihypertensives: olanzapine can cause orthostatic hypotension, requiring blood pressure monitoring.
  • Antidiabetic drugs: potential for altered glucose control, necessitating glycemic monitoring.

Frequently Asked Questions

Olanzapin Heumann contains olanzapine, an atypical antipsychotic indicated for the management of schizophrenia and for the treatment of manic episodes associated with bipolar disorder in adult patients. It helps reduce psychotic symptoms and stabilise mood.

Olanzapine works by blocking dopamine D2 receptors and serotonin 5‑HT2A receptors, which reduces excessive dopaminergic activity and modulates serotonergic transmission. This combined antagonism helps alleviate psychotic symptoms and contributes to mood stabilization.

The appropriate dose of Olanzapin Heumann is determined by the prescribing clinician based on the individual’s diagnosis, severity of symptoms, prior treatment response and tolerability. Dosage adjustments are made according to clinical judgment and patient monitoring.

Safety data for olanzapine in pregnancy and lactation are limited. The prescriber must weigh potential benefits against possible risks to the fetus or infant. If treatment is essential, it should be continued under close medical supervision, and breastfeeding decisions should follow current clinical guidelines.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Olanzapin Heumann (olanzapine) is an atypical antipsychotic with strong dopamine D2 and serotonin 5‑HT2A antagonism, offering efficacy for both psychosis and mood stabilization. Compared with some older agents, it may have a higher propensity for metabolic side effects but often provides better control of both positive and negative symptoms.

Olanzapin Heumann should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from excess moisture, heat and direct light to maintain its stability throughout its shelf life.

Olanzapin Heumann is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact administration schedule and any food considerations are determined by the treating clinician based on the patient’s therapeutic plan.

Serious risks include neuroleptic malignant syndrome, severe hyperglycemia, agranulocytosis, seizures, and tardive dyskinesia. Patients should be monitored regularly for signs of these conditions, and any concerning symptoms should prompt immediate medical evaluation.

Olanzapin Heumann is contraindicated in individuals with known hypersensitivity to olanzapine or any of its excipients. It should be used with caution, or avoided, in patients with uncontrolled diabetes, severe cardiovascular disease, a history of seizures, or in elderly patients with dementia‑related psychosis due to increased mortality risk.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Olanzapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT